This study explored the clinical value of MYO1E DNA methylation and MYO1E RNA expression in NSCLC based on publicly available (TCGA) data, as well as data from two international medical centers (University of Illinois Chicago, USA and University Hospital of Patras, Greece). The gene discussed is MYO1E; the disease is non-small cell lung carcinoma.